SEC Form 3 · accession 0001144204-15-046379
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Knoll Capital Management, LP
10% Owner
Period of report
Nov 24, 2014
Accepted (ET)
Aug 5, 2015 · 11:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,750,000 | I | By Europa International, Inc. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to Purchase Common StockF1 | $1.00 | holding | — | — | — | Apr 11, 2014 | Aug 26, 2015 | Common Stock | 1,000,000 | — | I |
Explanation of responses
- F1Knoll Capital Management, L.P, the investment Manager for Europa International, Inc., exercises voting and dispositive power over the shares held by Europa International, Inc., but disclaims any beneficial interest in the shares of common stock owned by Europa International, Inc. except to the extent of its pecuniary interest therein.